Bulletin
Investor Alert

Exact Sciences Corp.

NAS: EXAS

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206653925/composite

$

106.80

Change

-1.35 -1.25%

Volume

Volume 282,711

Sep 17, 2021, 7:57 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206653925/composite

Previous close

$ 102.79

$ 108.15

Change

+5.36 +5.21%

Day low

Day high

$101.22

$108.99

Open
Open: 102.34

52 week low

52 week high

$70.75

$159.54

Open

Market cap

$18.60B

Average volume

1.34M

P/E ratio

N/A

Rev. per Employee

$298,278

EPS

-5.47

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/exas

MarketWatch News on EXAS

  1. Equipment-Buying Wave Is Coming, and It Should Boost Cisco

    10:15 p.m. Sept. 17, 2021

    - Barron's Online

  2. Will Illumina’s Purchase of Grail Kill Cancer-Test Competition?

    7:49 a.m. Aug. 30, 2021

    - Barron's Online

  3. How Natera Is Defending Its Lead in a $15B Cancer-Testing Market

    10:34 a.m. June 22, 2021

    - Barron's Online

  4. Exact Sciences initiated at strong buy with $160 price target at Raymond James

    7:45 a.m. June 15, 2021

    - Tonya Garcia

  5. Grail Will Begin Selling Its Multi-Cancer Blood Test

    9:10 a.m. June 4, 2021

    - Barron's Online

  6. Exact Sciences stock price target cut to $168 from $226 at Truist

    7:59 a.m. May 12, 2021

    - Tomi Kilgore

  7. ARK Innovation ETF Is Struggling Again—and It May Get Worse

    3:13 p.m. May 6, 2021

    - Barron's Online

  8. How a Simple Blood Test Could Reduce Cancer Deaths

    7:26 a.m. April 12, 2021

    - Barron's Online

  9. The FTC Wants to Block Illumina's Deal for Grail

    8:58 a.m. March 31, 2021

    - Barron's Online

  10. Exact Sciences started at buy with $226 stock price target at Truist

    8:42 a.m. Jan. 28, 2021

    - Tomi Kilgore

  11. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/exas

Other News on EXAS

  1. The 1 Stock I'd Buy Right Now

    7:05 a.m. Today

    - Motley Fool

  2. Exact Sciences adds former Pfizer employees to sales team

    8:40 a.m. Sept. 15, 2021

    - Seeking Alpha

  3. 3 Crash-Ready Stocks to Buy in September

    9:05 a.m. Sept. 14, 2021

    - Motley Fool

  4. PAVmed: Long Term Investment Case Remains Despite Weak Q2

    11:52 a.m. Aug. 23, 2021

    - Seeking Alpha

  5. 3 Top Healthcare Stocks to Buy for August

    9:15 a.m. Aug. 19, 2021

    - Motley Fool

  6. Invitae jumps on news of merger offer from Exact Sciences

    5:48 p.m. Aug. 6, 2021

    - Seeking Alpha

  7. 10 Stocks to Buy From Cathie Wood’s Fleet of ETFs 

    10:45 a.m. Aug. 6, 2021

    - InvestorPlace.com

  8. Bear of the Day: NeoGenomics (NEO)

    6:20 a.m. July 30, 2021

    - Zacks.com

  9. Loading more headlines...
/news/pressrelease/company/us/exas

Press Releases on EXAS

  1. 3 Biotech Penny Stocks To Watch On Robinhood IPO Day

    10:57 a.m. July 30, 2021

    - Penny Stocks

  2. Exagen Appoints Ana Hooker to Board of Directors

    8:25 a.m. July 30, 2021

    - GlobeNewswire

  3. Exact Sciences Announces Second Quarter 2021 Results

    4:05 p.m. July 28, 2021

    - PR Newswire - PRF

  4. Cancer Diagnostics Global Market - Forecast to 2026

    11:03 p.m. July 15, 2021

    - Comserve

  5. Cancer Diagnostics Global Market - Forecast to 2026

    5:52 a.m. July 15, 2021

    - Comserve

  6. Genomics Global Market - Forecast to 2027

    3:24 a.m. July 15, 2021

    - Comserve

  7. Exact Sciences schedules second quarter 2021 earnings call

    6:00 a.m. July 8, 2021

    - PR Newswire - PRF

  8. Biopreservation Market Size, Share, Trends, Analysis and Forecast 2027

    6:47 a.m. June 28, 2021

    - Market Insight Reports

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.